EPGL
TAK icon

Evelyn Partners Group Ltd’s Takeda Pharmaceutical TAK Stock Holding History

Evelyn Partners Group Ltd’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.36K Buy
+272
New +$4.5K ﹤0.01% 513

Other funds holding TAK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAP
Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Evelyn Partners Group Ltd's TAK Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 272 shares worth $4.36K. The stake represents ﹤0.01% of the portfolio and ranks #513 among its holdings.

201 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Evelyn Partners Group Ltd held 272 shares of Takeda Pharmaceutical worth $4.36K as of Q2 2026.
  • Takeda Pharmaceutical was a new Evelyn Partners Group Ltd position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #513 holding.
  • 201 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.